Tat PTD-Endostatin-RGD: A novel protein with anti-angiogenesis effect in retina via eye drops.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Biochimica et Biophysica Acta

• Publication date

  2016-10-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bbagen.2016.05.031PMID 27233450
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Translation and validation of diabetes self-management profile (DSMP) into Brazilian Portuguese language: first instrument to assess type 1 diabetes self-management in a pediatric population

  2017cited by this paper
• Inhibitory effect of Samul-tang on retinal neovascularization in oxygen-induced retinopathy

  2015cited by this paper
• Diabetic retinopathy--biomolecules and multiple pathophysiology.

  2015cited by this paper
• Radiosynthesis and micro-SPECT analysis of triazole-based RGD integrin ligands as non-peptide molecular imaging probes for angiogenesis.

  2015cited by this paper
• Tat PTD-endostatin: A novel anti-angiogenesis protein with ocular barrier permeability via eye-drops.

  2015cited by this paper
• Wide-field imaging and OCT vs clinical evaluation of patients referred from diabetic retinopathy screening

  2015cited by this paper
• Pharmacokinetics of HM-3 After Intravitreal Administration in Mice

  2014cited by this paper
• Anti-Angiogenic Effects of a Mutant Endostatin: A New Prospect for Treating Retinal and Choroidal Neovascularization

  2014cited by this paper
• Endostar, a Modified Recombinant Human Endostatin, Suppresses Angiogenesis through Inhibition of Wnt/β-Catenin Signaling Pathway

  2014cited by this paper
• Therapeutic efficacy of a novel non-peptide αvβ3 integrin antagonist for pathological retinal angiogenesis in mice.

  2014cited by this paper
• Bevacizumab treatment reduces retinal neovascularization in a mouse model of retinopathy of prematurity.

  2014cited by this paper
• Klebsiella pneumoniae Induces an Inflammatory Response in an In Vitro Model of Blood-Retinal Barrier

  2013cited by this paper
• Long-term outcomes in ranibizumab-treated patients with retinal vein occlusion; the role of progression of retinal nonperfusion.

  2013cited by this paper
• Ocular neovascularization

  2013cited by this paper
• Intravitreal injection of TIMP3 or the EGFR inhibitor erlotinib offers protection from oxygen-induced retinopathy in mice.

  2013cited by this paper
• Hesperidin Prevents Retinal and Plasma Abnormalities in Streptozotocin-Induced Diabetic Rats

  2012cited by this paper
• Human Blood-Brain Barrier Endothelial Cells Derived from Pluripotent Stem Cells

  2012cited by this paper
• Global Prevalence and Major Risk Factors of Diabetic Retinopathy

  2012cited by this paper
• Chick Chorioallantoic Membrane (CAM) Assay as an In Vivo Model to Study the Effect of Newly Identified Molecules on Ovarian Cancer Invasion and Metastasis

  2012cited by this paper
• Central nervous system pericytes in health and disease

  2011cited by this paper
• The blood-retinal barrier: structure and functional significance.

  2011cited by this paper
• The blood-brain and other neural barriers : reviews and protocols

  2011cited by this paper
• αV integrins in angiogenesis and cancer.

  2011cited by this paper
• Deletion of Adam10 in endothelial cells leads to defects in organ-specific vascular structures.

  2011cited by this paper
• Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis

  2009cited by this paper
• Cell migration and proliferation during monolayer formation and wound healing

  2009cited by this paper
• Increased dietary intake of ω-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis

  2007cited by this paper
• The blood-ocular barriers: past, present, and future

  2007cited by this paper
• Corneal Epithelial Testing Strategies for Safety Evaluation of Ophthalmic Formulations

  2007cited by this paper
• Ocular neovascularization: basic mechanisms and therapeutic advances.

  2007cited by this paper
• Downregulation of vascular endothelial growth factor and integrinbeta3 by endostatin in a mouse model of retinal neovascularization.

  2006cited by this paper
• Wound-healing assay.

  2005cited by this paper
• Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

  2004cited by this paper
• NO and angiogenesis.

  2003cited by this paper
• Deficiency in endothelial nitric oxide synthase impairs myocardial angiogenesis.

  2002cited by this paper
• Endostatin Blocks Vascular Endothelial Growth Factor-mediated Signaling via Direct Interaction with KDR/Flk-1*

  2002cited by this paper
• Nitric Oxide Induces Angiogenesis and Upregulates αvβ3 Integrin Expression on Endothelial Cells

  2000cited by this paper
• Nitric oxide induces angiogenesis and upregulates alpha(v)beta(3) integrin expression on endothelial cells.

  2000cited by this paper
• Ocular irritancy assessment of cosmetics formulations and ingredients: fluorescein leakage test.

  1999cited by this paper
• Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy.

  1997cited by this paper
• Essential role of growth hormone in ischemia-induced retinal neovascularization.

  1997cited by this paper
• Evaluation of chemically induced toxicity using an in vitro model of human corneal epithelium.

  1997cited by this paper
• P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.

  1996cited by this paper
• Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane.

  1995cited by this paper
• Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin.

  1995cited by this paper
• Molecular and biological properties of the vascular endothelial growth factor family of proteins.

  1992cited by this paper
• Uptake of neoglycoproteins via membrane lectin(s) of L1210 cells evidenced by quantitative flow cytofluorometry and drug targeting

  1984cited by this paper
• The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years.

  1984cited by this paper

• Evolving roles of drug delivery systems for non-invasive treatment of neovascular age-related macular degeneration: advances and challenges

  2026cites this paper
• Peptide‐Bound Aflibercept Eye Drops for Treatment of Neovascular Age‐Related Macular Degeneration in Nonhuman Primates

  2025cites this paper
• Asprosin activates multiple placental pathways in vitro: Evidence for potential involvement in angiogenesis, fatty acid metabolism and the mTOR, NOTCH and WNT signalling pathways

  2025cites this paper
• Topical Ocular Drug Delivery: The Impact of Permeation Enhancers

  2025cites this paper
• Construction and in vitro activity evaluation of protein transduction domain-transactivator of transcription and Candida antarctica lipase B fusion proteins

  2025cites this paper
• AI-Driven Design of Cell-Penetrating Peptides for Therapeutic Biotechnology

  2024cites this paper
• Endostatin in disease modulation: From cancer to beyond.

  2024cites this paper
• A Novel Blood–Brain Barrier-Penetrating and Vascular-Targeting Chimeric Peptide Inhibits Glioma Angiogenesis

  2023cites this paper
• Ocular Delivery of Therapeutic Proteins: A Review

  2023cites this paper
• Peptide cargo administration: current state and applications

  2023cites this paper
• Ocular therapies with biomacromolecules: From local injection to eyedrop and emerging noninvasive delivery strategies.

  2023cites this paper
• Machine learning-driven multifunctional peptide engineering for sustained ocular drug delivery

  2023cites this paper
• Innovative Strategies for Drug Delivery to the Ocular Posterior Segment

  2023cites this paper
• Liraglutide Treatment Does Not Induce Changes in the Peripapillary Retinal Nerve Fiber Layer Thickness in Patients with Diabetic Retinopathy

  2021cites this paper
• Penetration Enhancers for Topical Drug Delivery to the Ocular Posterior Segment—A Systematic Review

  2021influential citation
• Peptidomimetics Therapeutics for Retinal Disease

  2021cites this paper
• Targeting RGD-binding integrins as an integrative therapy for diabetic retinopathy and neovascular age-related macular degeneration.

  2021cites this paper
• CRISPR-dcas9 Optogenetic Nanosystem for the Blue Light-Mediated Treatment of Neovascular Lesions.

  2021cites this paper
• Decreased endostatin in db/db retinas is associated with optic disc intravitreal vascularization.

  2021cites this paper
• Differential effects of risuteganib and bevacizumab on AMD cybrid cells.

  2020cites this paper
• SOCS1-Derived Peptide Administered by Eye Drops Prevents Retinal Neuroinflammation and Vascular Leakage in Experimental Diabetes

  2019cites this paper
• Effects of Topically Administered Neuroprotective Drugs in Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial

  2018cites this paper
• Cell penetrating peptides in ocular drug delivery: State of the art.

  2018cites this paper
• Anti-angiogenic activity and mechanism of a chemically sulfated natural glucan from Phellinus ribis.

  2018cites this paper
• Retinal and choroidal angiogenesis: a review of new targets

  2017cites this paper
• Osteogenic activity and angiogenesis of a SrTiO3 nano-gridding structure on titanium surface.

  2017cites this paper
• Perspectives in New Advances in Retinal Neovascularization Pathogenesis and Therapeutic Approaches

  2017cites this paper
• A Critical Analysis of the Available In Vitro and Ex Vivo Methods to Study Retinal Angiogenesis

  2017cites this paper